Urinary dysfunction in multiple sclerosis
Nemer M.N. Abdallax,
I. I. Belousov,
Z. A. Goncharova,
R. S. Ismailov,
O. Yu. Rudenko,
A. S. Pchelkin https://doi.org/10.21886/2712-8156-2024-5-1-23-31
Abstract
This review presents the relevance of mandatory assessment of the function of the lower urinary tract in multiple sclerosis to identify the lower urinary tract symptoms, the nature and severity of disability in patients regarding urinary disorders. Lower urinary tract symptoms in multiple sclerosis are diverse and correlate with the phases of the urination cycle. lower urinary tract symptoms in multiple sclerosis include urinary urgency or sporadic episodes of urinary retention. As the disease progresses, along with urgency and sensory disturbances, urinary incontinence develops, resulting in total urinary incontinence in the most severe cases. Chronic urine retention may also form, which determines the need to urine diversion from the bladder through urethral drainage. In turn, the risk of developing urinary tract infections, including catheter-associated ones, increases significantly.
About the Authors
Nemer M.N. Abdallax
Rostov State Medical University
Russian Federation
Russian Federation
Abdallax Nemer M.N., postgraduate student (PhD) of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)
Rostov-on-Don
I. I. Belousov
Rostov State Medical University
Russian Federation
Russian Federation
Belousov Igor I., Dr. Sci. (Med.), Professor of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)
Rostov-on-Don
Z. A. Goncharova
Rostov State Medical University
Russian Federation
Russian Federation
Goncharova Zoya A., Dr. Sci. (Med.), Professor of the Department of Nervous Diseases and Neurosurgery, Rostov State Medical University, Head of the Neurological Center of the Clinic of the Rostov State Medical University
Rostov-on-Don
R. S. Ismailov
Rostov State Medical University
Russian Federation
Russian Federation
Ismailov Ruslan S., Cand. Sci. (Med.), assistant of the Department of Urology and Human Reproductive Health (with a course of pediatric Urology-Andrology)
Rostov-on-Don
O. Yu. Rudenko
Rostov State Medical University
Russian Federation
Russian Federation
Rudenko Olga Yu., Cand. Sci. (Med.), assistant of the Department of Nervous Diseases and Neurosurgery
Rostov-on-Don
A. S. Pchelkin
Rostov State Medical University
Russian Federation
Russian Federation
Pchelkin Artem S., 6th year student, Faculty of General Medicine
Rostov-on-Don
References
1. Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur J Neurol. 2018;25(2):215-237. Erratum in: Eur J Neurol. 2018;25(3):605. PMID: 29352526. DOI: 10.1111/ene.13536.
2. Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777-788. Erratum in: Neurology. 2019;92(2):112. DOI: 10.1212/WNL.0000000000005347.
3. Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409-416. DOI: 10.2174/157015911796557911
4. Boyko A, Smirnova N, Petrov S, Gusev E. Epidemiology of MS in Russia, a historical review. Mult Scler Demyelinating Disord. 2016;13:1. DOI: 10.1186/s40893-016-0016-9
5. Boynova I.V., Samarina D.V., Katorova A.V., Tokareva N.G. Clinical and epidemiological features of multiple sclerosis in the Russian Federation. Modern problems of science and education. 2022;(5):138. (In Russ.) DOI: 10.17513/spno.32006
6. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020;10(5):305. DOI: 10.3390/brainsci10050305
7. Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752-759. DOI: 10.1097/WCO.0000000000000622
8. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-86. DOI: 10.1212/WNL.0000000000000560
9. Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change. Curr Opin Neurol. 2019;32(3):327-337. DOI: 10.1097/WCO.0000000000000699
10. Sakakibara R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res. 2019;29(3):313-320. DOI: 10.1007/s10286-018-0551-x
11. Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn. 2015;34(1):32-36. DOI: 10.1002/nau.22495
12. Zecca C, Riccitelli GC, Disanto G, Singh A, Digesu GA, Panicari L, et al. Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life. Eur J Neurol. 2016;23(7):1228-1234. DOI: 10.1111/ene.13010
13. Inojosa H, Schriefer D, Ziemssen T. Clinical outcome measures in multiple sclerosis: A review. Autoimmun Rev. 2020;19(5):102512. DOI: 10.1016/j.autrev.2020.102512
14. Nazari F, Shaygannejad V, Mohammadi Sichani M, Mansourian M, Hajhashemi V. The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis. BMC Neurol. 2020;20(1):24. DOI: 10.1186/s12883-019-1582-1
15. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-466. DOI: 10.1038/nrn2401
16. Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008;371(9609):283-285. DOI: 10.1016/S0140-6736(08)60145-2. PMID: 18294983.
17. Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol. 2007;64(1):76-80. DOI: 10.1001/archneur.64.1.76
18. Schmierer K, McDowell A, Petrova N, Carassiti D, Thomas DL, Miquel ME. Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI. Neuroimage. 2018;182:251-258. DOI: 10.1016/j.neuroimage.2018.01.052
19. Ramasamy R, Smith PP. Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research. Neurourol Urodyn. 2021;40(4):950-957. DOI: 10.1002/nau.24649
20. Sparaco M, Bonavita S. Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis. J Clin Med. 2022;11(7):1941. DOI: 10.3390/jcm11071941
21. Al Dandan HB, Coote S, McClurg D. Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis. Int J MS Care. 2020;22(2):91-99. DOI: 10.7224/1537-2073.2019-030
22. de Sèze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B; GENULF. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13(7):915-928. DOI: 10.1177/1352458506075651
23. Seddone S, Marturano M, Bientinesi R, Lucchini M, Bassi P, Mirabella M, Nociti V. Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments. Neurourol Urodyn. 2021;40(6):1500-1508. DOI: 10.1002/nau.24687
24. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116-126. DOI: 10.1067/mob.2002.125704
25. Faithfull S, Lemanska A, Aslet P, Bhatt N, Coe J, Drudge-Coates L, et al. Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies. Int J Clin Pract. 2015;69(10):1184-1208. DOI: 10.1111/ijcp.12693
26. D'Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433-477. DOI: 10.1002/nau.23897
27. Amarenco G, de Sèze M, Ruffion A, Sheikh Ismael S. Clinical and urodynamic evaluations of urinary disorders in multiple sclerosis. Ann Phys Rehabil Med. 2014;57(5):277-287. DOI: 10.1016/j.rehab.2014.05.006
28. Ziryanov A.V., Bazhenov I.V., Philippova E.S., Ustinov G.S., Turova E.L., Toreyev I.O., et al. Epidemiology and characteristics of urinary tract dysfunction in multiple sclerosis patients. Urology Herald. 2020;8(2):29-36. (In Russ.) DOI: 10.21886/2308-6424-2020-8-2-29-36
29. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988-1000. DOI: 10.1016/j.eururo.2019.02.038
30. Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37(3):1152-1161. DOI: 10.1002/nau.23397
31. Rahnama'i MS. Neuromodulation for functional bladder disorders in patients with multiple sclerosis. Mult Scler. 2020;26(11):1274-1280. DOI: 10.1177/1352458519894714
32. Qin C, Wang Y, Gao Y. Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology. Front Physiol. 2021;12:747144. DOI: 10.3389/fphys.2021.747144
33. Shvarts P.G., Dutov V.V. Polymorphism of the syndrome of hyperactive urinary bladder in patients with acute and chronic vascular diseases of the brain. Urology Herald. 2016;(3):41-60. (In Russ.) DOI: 10.21886/2308-6424-2016-0-3-41-60
34. Vieira B, Costa A, Videira G, Sá MJ, Abreu P. Prevalence of autonomic dysfunction in patients with multiple sclerosis. Acta Med Port. 2015;28(1):51-55. DOI: 10.20344/amp.5562
Review
For citations:
Abdallax N.M., Belousov I.I., Goncharova Z.A., Ismailov R.S., Rudenko O.Yu., Pchelkin A.S. Urinary dysfunction in multiple sclerosis. South Russian Journal of Therapeutic Practice. 2024;5(1):23-31. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-1-23-31
Views:
6037
Email this article 